Population Pharmacokinetic (POPPK) Model for Ertugliflozin in Healthy Subjects and Type 2 Diabetes Mellitus (T2DM) Patients

被引：0
|
作者：
Fediuk, Daryl J. [1 ]
Sweeney, Kevin [1 ]
Zhou, Susan [2 ]
Kumar, Vikas [1 ]
Sahasrabudhe, Vaishali [1 ]
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-035
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
    Fediuk, Daryl J.
    Zhou, Susan
    Dawra, Vikas Kumar
    Sahasrabudhe, Vaishali
    Sweeney, Kevin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 696 - 706
  • [2] Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Pong, Annpey
    Huyck, Susan
    Wu, Larry
    Mancuso, James P.
    Terra, Steven
    Lauring, Brett
    DIABETES, 2018, 67
  • [3] Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Ellison, Misoo C.
    Pong, Annpey
    Huyck, Susan
    Mancuso, James P.
    Terra, Steven G.
    Gantz, Ira
    DIABETES, 2019, 68
  • [4] Assessment of Adverse Renal Effects in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Patel, Shrita M.
    Hickman, Mary A.
    Frederich, Robert
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Huyck, Susan
    Mancuso, James P.
    DIABETES, 2018, 67
  • [5] Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
    Kun Wang
    Lingge Feng
    Jiayi Zhang
    Quanfei Zou
    Fengyan Xu
    Zhongyi Sun
    Fuxing Tang
    Li Chen
    Clinical Pharmacokinetics, 2023, 62 : 1413 - 1425
  • [6] Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
    Wang, Kun
    Feng, Lingge
    Zhang, Jiayi
    Zou, Quanfei
    Xu, Fengyan
    Sun, Zhongyi
    Tang, Fuxing
    Chen, Li
    CLINICAL PHARMACOKINETICS, 2023, 62 (10) : 1413 - 1425
  • [7] Evaluation of Osmotic Diuresis and Volume Depletion Events in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Patel, Shrita M.
    Hickman, Mary A.
    Frederich, Robert
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Huyck, Susan
    Mancuso, James P.
    DIABETES, 2018, 67
  • [8] First Human Dose Escalation Study with Remogliflozin Etabonate (RE) in Healthy Subjects and in Subjects with Type 2 Diabetes Mellitus (T2DM)
    Kapur, Anita
    O'Connor-Semmes, Robin L.
    Hussey, Elizabeth K.
    Dobbins, Robert L.
    Tao, Wenli
    Hompesch, Marcus
    Nunez, Derek J.
    DIABETES, 2009, 58 : A136 - A136
  • [9] Evaluation of Fractures, Bone Mineral Density (BMD), and Bone Biomarkers in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Hickman, Mary A.
    Frederich, Robert
    Patel, Shrita M.
    Gallo, Silvina
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Masiukiewicz, Urszula
    Huyck, Susan
    Mancuso, James P.
    DIABETES, 2018, 67
  • [10] Characteristics of a large urban pediatric population with type 2 diabetes mellitus (T2DM)
    Katz, LEL
    Norris, R
    Weinzimer, SA
    Jawad, AF
    Preis, CM
    McKnight, H
    Murphy, KM
    DIABETES, 2001, 50 : A380 - A380
12345